JSP
CRL icon

Jackson Square Partners’s Charles River Laboratories CRL Stock Holding History

Jackson Square Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-134,927
Closed -$24.9M – 56
2024
Q4 		$24.9M Sell
134,927
-26,998
-17% -$5.2M 2.59% 12
2024
Q3 		$31.9M Sell
161,925
-16,301
-9% -$3.39M 2.75% 14
2024
Q2 		$36.8M Sell
178,226
-73,082
-29% -$16.6M 2.25% 22
2024
Q1 		$68.1M Sell
251,308
-98,183
-28% -$23.4M 2.83% 13
2023
Q4 		$82.6M Buy
349,491
+80,873
+30% +$15.9M 2.68% 17
2023
Q3 		$52.6M Sell
268,618
-322,623
-55% -$66.2M 1.76% 27
2023
Q2 		$124M Sell
591,241
-312,726
-35% -$62.2M 3.63% 8
2023
Q1 		$182M Buy
903,967
+42,844
+5% +$9.71M 4.93% 5
2022
Q4 		$188M Sell
861,123
-9,665
-1% -$2.11M 5% 3
2022
Q3 		$171M Buy
870,788
+435,318
+100% +$94M 4.49% 3
2022
Q2 		$93.2M Buy
435,470
+434,809
+65,780% +$106M 2.18% 22
2022
Q1 		$187K Buy
+661
New +$204K ﹤0.01% 93

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jackson Square Partners's CRL Position: Q1 2025 in Review

Jackson Square Partners sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 134,927 shares — an estimated $24.9M sold.

Jackson Square Partners first reported a position in CRL in Q1 2022 and held it in 12 quarters. The position peaked at $188M in Q4 2022. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Jackson Square Partners reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Jackson Square Partners sold 134,927 Charles River Laboratories shares in Q1 2025, an estimated $24.9M.
  • Jackson Square Partners first reported a position in Charles River Laboratories in Q1 2022 and held it in 12 quarters.
  • Jackson Square Partners's Charles River Laboratories position peaked at $188M in Q4 2022.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Jackson Square Partners's 13F filing for Q1 2025, filed 12 May 2025.